| Literature DB >> 27690061 |
Song Huang1, Haiyan Chen2, Wensheng Li3, Xinwei Zhu4, Weijia Ding5, Chunyuan Li6.
Abstract
A novel chaetoglobosin named penochalasin I (1) with a unprecedented six-cyclic 6/5/6/5/6/13 fused ring system, and another new chaetoglobosin named penochalasin J (2), along with chaetoglobosins G, F, C, A, E, armochaetoglobosin I, and cytoglobosin C (3-9) were isolated from the culture of Penicillium chrysogenum V11. Their structures were elucidated by 1D, 2D NMR spectroscopic analysis and high resolution mass spectroscopic data. The absolute configuration of compounds 1 and 2 were determined by comparing the theoretical electronic circular dichroism (ECD) calculation with the experimental CD. Compound 1 was the first example, with a six-cyclic fused ring system formed by the connection of C-5 and C-2' of the chaetoglobosin class. Compounds 5-8 remarkably inhibited the plant pathogenic fungus R. solani (minimum inhibitory concentrations (MICs) = 11.79-23.66 μM), and compounds 2, 6, and 7 greatly inhibited C. gloeosporioides (MICs = 23.58-47.35 μM), showing an antifungal activity higher than that of carbendazim. Compound 1 exhibited marked cytotoxicity against MDA-MB-435 and SGC-7901 cells (IC50 < 10 μM), and compounds 6 and 9 showed potent cytotoxicity against SGC-7901 and A549 cells (IC50 < 10 μM).Entities:
Keywords: Penicillium chrysogenum; antifungal activity; chaetoglobosin; cytotoxicity; marine mangrove fungus
Year: 2016 PMID: 27690061 PMCID: PMC5082320 DOI: 10.3390/md14100172
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Chemical structures of the isolated compounds 1–9.
1H and 13C NMR data for compounds 1–2.
| No. | 1 a | 2 a | ||
|---|---|---|---|---|
| 1 | 173.9, C | 175.0, C | ||
| 2-NH | 7.61, s | unobservable | ||
| 3 | 53.4, CH | 3.75, m (10.2) | 54.6, CH | 3.47, m |
| 4 | 52.5, CH | 3.25, d (10.2) | 51.6, CH | 2.62, d (3.6) |
| 5 | 41.8, C | 36.1, CH | 2.40, m | |
| 6 | 142.3, C | 140.4, C | ||
| 7 | 124.9, CH | 5.19, t (1.8) | 126.8, CH | 5.32, m |
| 8 | 41.5, CH | 3.07, dt (9.6, 2.4) | 48.5, CH | 2.77, d (10.2) |
| 9 | 61.9, C | 67.5, C | ||
| 10 | 29.1, CH2 | a2.55, dd (13.8, 10.8) | 33.4, CH2 | a2.80, dd (14.4, 4.8) |
| b3.19, dd (13.8, 10.8) | b2.99, d (4.2) | |||
| 11 | 23.2, CH3 | 1.41, s | 14.0, CH3 | 1.23, d (7.2) |
| 12 | 21.5, CH3 | 1.66, s | 20.2, CH3 | 1.77, s |
| 13 | 133.1, CH | 5.68, qd (15.4, 10.2, 2.4) | 131.8, CH | 6.01, ddd (15.0, 10.2, 1.8) |
| 14 | 133.7, CH | 5.42, td (15.4, 10.8, 2.4) | 131.8, CH | 5.02, ddd (15.0, 10.8, 3.6) |
| 15 | 41.1, CH2 | a2.06, m | 42.5, CH2 | a1.84, m |
| b2.45, m | b2.17, m | |||
| 16 | 33.6, CH | 2.77, m | 33.2, CH | 2.44, m |
| 16-CH3 | 21.0, CH3 | 1.07, d (6.6) | 21.8, CH3 | 0.91, d (6.6) |
| 17 | 140.3, CH | 5.60, dd (10.8, 1.8) | 137.7, CH | 5.07, d (9.0) |
| 18 | 133.4, C | 129.1, C | ||
| 18-CH3 | 11.2, CH3 | 1.48, s | 16.4, CH3 | 1.55, s |
| 19 | 82.7, CH | 4.98, d (4.8) | 53.9, CH2 | a2.66, d (15.6) |
| b3.01, d (15.6) | ||||
| 19-OH | 4.22, d (4.8) | |||
| 20 | 201.7, C | 209.7, C | ||
| 21 | 133.3, CH | 6.76, d (16.8) | 36.9, CH2 | a1.80, m |
| b2.21, m | ||||
| 22 | 138.8, CH | 8.23, d (16.8) | 37.9, CH2 | a1.60, m |
| b3.08, m | ||||
| 23 | 198.2, C | 210.2, C | ||
| 1′-NH | 10.29, s | 10.16, s | ||
| 1′a | 137.8, C | 137.5, C | ||
| 2′ | 139.9, C | 125.6, CH | 7.13, s | |
| 3′ | 108.4, C | 110.5, C | ||
| 3′a | 127.9, C | 128.9, C | ||
| 4′ | 118.7, CH | 7.44, d (7.8) | 119.5, CH | 7.56 d (7.8) |
| 5′ | 119.9, CH | 7.01, t (8.4, 7.8) | 119.9, CH | 6.99 t (8.4, 7.8) |
| 6′ | 122.1, CH | 7.08, t (8.4, 7.8) | 122.1, CH | 7.04 t (8.4, 7.8) |
| 7′ | 111.9, CH | 7.34, d (8.4) | 112.4, CH | 7.35 d (8.4) |
a Measured in CD3COCD3 at 600 MHz (1H) and 150 MHz (13C).
Figure 2Key heteronuclear multiple bond correlation (HMBC, arrows) and chemical-shift correlation spectroscopy (COSY, bold lines) correlations of compounds 1 and 2.
Figure 3Key nuclear overhauser effect spectroscopy (NOESY) correlations of compounds 1 and 2.
Figure 4(a) Experimental circular dichroism (CD) of 1, and (b) calculated electronic CD (ECD) of 1 in MeOH.
Figure 5(a) Experimental CD of 2, and (b) calculated ECD of 2 in MeOH.
The antifungal activity of the isolated compounds by the minimum inhibitory concentration (MIC) values (μM).
| Compounds | ||||
|---|---|---|---|---|
| >391.96 | >391.96 | 195.98 | >391.96 | |
| 100.34 | 100.34 | 50.17 | 25.08 | |
| 47.14 | 47.14 | ND | 94.29 | |
| 94.65 | 94.65 | 23.66 | 94.65 | |
| 94.70 | 94.70 | 11.83 | 47.35 | |
| 94.34 | 23.58 | 11.79 | 23.58 | |
| 96.90 | 48.45 | 12.11 | ND | |
| Carbendazim a | 32.69 | 16.34 | 32.69 | 65.38 |
a presented as positive control; ND—not determined.
Cytotoxicity (IC50, μM) a of compounds 1–9 against MDA-MB-435, SGC-7901, and A549 cell lines.
| Compounds | Cell Lines | ||
|---|---|---|---|
| MDA-MB-435 | SGC-7901 | A549 | |
| 7.55 ± 0.71 | 7.32 ± 0.68 | 16.13 ± 0.82 | |
| 36.68 ± 0.90 | 37.70 ± 1.30 | 35.93 ± 0.66 | |
| 38.77 ± 0.65 | 25.86 ± 0.84 | 27.63 ± 0.45 | |
| 37.77 ± 0.41 | 26.53 ± 0.56 | 27.72 ± 0.81 | |
| 19.97 ± 1.03 | 15.36 ± 0.89 | 17.82 ± 0.85 | |
| 37.56 ± 0.95 | 7.48 ± 1.01 | 6.56 ± 0.67 | |
| >40 | >40 | 36.63 ± 0.45 | |
| >40 | >40 | >40 | |
| 12.58 ± 0.90 | 8.15 ± 0.64 | 3.35 ± 0.47 | |
| Epirubicin b | 0.56 ± 0.06 | 0.37 ± 0.11 | 0.61 ± 0.05 |
a IC50 values are taken as means ± standard deviation from three independent experiments; b Used as a positive control.